Madrigal Pharmaceuticals Secures $500MM from Blue Owl Managed Funds
Madrigal Pharmaceuticals, a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), entered into a $500 million...








